Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Romiplostim |
Thrombopoietin Receptor Agonist | Hematologic (Thrombocytopenia) | ||
|
Molecule
Romiplostim
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Thrombocytopenia)
Drug Class / Mechanism
Thrombopoietin Receptor Agonist |
||||
Romosozumab (Onc-Adjacent Bone) |
RANKL Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Romosozumab (Onc-Adjacent Bone)
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
RANKL Inhibitor |
||||
Ropeginterferon Alfa-2b |
G-CSF / GM-CSF Analogue | Both (Solid & Hematologic) | ||
|
Molecule
Ropeginterferon Alfa-2b
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
||||
Rubitecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Rubitecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Sabarubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Sabarubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Sagopilone |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Sagopilone
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Sapacitabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Sapacitabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Sargramostim (GM-CSF) |
G-CSF / GM-CSF Analogue | Both (Solid & Hematologic) | ||
|
Molecule
Sargramostim (GM-CSF)
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
||||
Satraplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Satraplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Scopolamine (Onc Adjunct) |
Corticosteroid / Antipsychotic / Antidopaminergic | Both (Solid & Hematologic) | ||
|
Molecule
Scopolamine (Onc Adjunct)
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
||||
Semustine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Semustine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Seviteronel |
CYP17 / Androgen Synthesis Inhibitor | Solid Tumour (Prostate) | ||
|
Molecule
Seviteronel
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
||||
RomiplostimSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Thrombocytopenia)
Drug Class / Mechanism
Thrombopoietin Receptor Agonist |
|
Romosozumab (Onc-Adjacent Bone)Bone-Modifying Agent |
|
|
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
RANKL Inhibitor |
|
Ropeginterferon Alfa-2bSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
|
RubitecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
SabarubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
SagopiloneCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
SapacitabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Sargramostim (GM-CSF)Supportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
G-CSF / GM-CSF Analogue |
|
SatraplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
Scopolamine (Onc Adjunct)Supportive Care (Antiemetic/Adjunct) |
|
|
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
|
SemustineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
SeviteronelHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
|